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Phosphorylated  β-(1→2)-oligomannosides  are  found  on  the  cell 
surface  of  several  Candida species,  including  C.  albicans (an 
opportunistic pathogen). These molecules are believed to take part 
in the invasion process of fungal infections, which in the case of C. 
albicans can lead to severe bloodstream infections and death, and 
can therefore be considered important from a biological standpoint. 
Understanding the mechanism of their action, requires access to the 
corresponding oligosaccharide model compounds in pure form. In 
the present work, synthesis of the model core structures involved in 
the   invasion  process  of  C.  albicans,  consisting  of 
phosphorylated  β-(1→2)-linked mannotriose  and  tetraose,  are 
reported. In order to elucidate the nature of these molecules in 
more  detail,  an  extensive  NMR-spectroscopic  study 
encompassing  complete  spectral  characterization, 
conformational  analysis  and  molecular  modelling  was 
performed. The obtained results were also compared to similar 
chemical entities devoid of the charged phosphate group.
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Introduction
Candida is  a  genus  of  fungi  that  causes  almost  96 % of  all 
opportunistic  fungal  infections.  It  is  the  fourth  most  commonly 
found pathogen in North American hospitals and the seventh in 
European hospitals.1a Candida albicans is the most common fungus 
and is part of the human microbial flora. As a result, the majority 
of fungal infections are caused by endogenic C. albicans.1b In usual 
cases,  this  does  not  cause  a  serious  threat,  but  in  people  with 
compromised immune systems, such as HIV patients and people 
undergoing prolonged chemotherapy or treatment with antibiotics, 
the fungi can grow uncontrollably and cause candidiasis leading to 
more serious infections.2a,b
The  cell  wall  of  C. albicans contains  a  glycoprotein, 
phosphopeptidomannan,  in  which  a  backbone  of  α-D-(1→6) 
mannopyranan with various mannoside side chains is coupled to 
asparagine through nitrogen. The side chains consist mainly of α-
(1→2)- and α-(1→3)-linked mannoses, as well as of additional  α-
(1→6)-linked mannose units. In addition, the cell wall contains a 
smaller amount of β-(1→2)-linked mannans bound to the branches 
either through a glycosidic bond (acid stable β-mannan) or through 
a phosphodiester bond (acid labile β-mannan) (Figure 1).3
The  β-linked  mannosides  isolated  from  the 
phosphopeptodonannan have on  multiple occasions been shown to 
stimulate  the  production  of  antibodies  against  candidasis. 
Consequently,  similar  compounds  have  become  attractive  target 
molecules for development of conjugate vaccines.2a,c-e 
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Figure  1.  Portion  of  the  C.  albicans cell  wall,  containing  β-(1→2)-
mannosides coupled to the backbone consisting of α-D-mannopyranan.
Due to the biological properties of these molecules, they have 
often been subjected to extensive biological studies, including  in 
vitro antibody binding studies, as well as in vivo studies in rabbits, 
mice and rats.2,4 Extracting the molecules from living organisms is 
tedious, and does not usually yield sufficient amounts of material 
for comprehensive biological studies. This is especially true for β-
linked mannosides, as they occur rather rarely, compared to some 
other  common  sugars  that  can  be  extracted  and  purified  from 
nature  in  large  scale.  Only  few  species  produce  the  β-linked 
mannosides at all, and even if they do, these molecules only make 
up a small portion of the total carbohydrates in these organisms. By 
further considering the problems associated with heterogeneity of 
the associated cell wall structures and the difficulties in isolating 
pure  compounds  devoid  of  biological  contaminations,  it  often 
becomes  preferable  or  even  mandatory  to  turn  into  synthetic 
organic chemistry for preparative solutions.
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In  recent  years,  the  synthesis  of  β-linked  mannosides  has 
received considerable attention and reliable methodologies for their 
synthesis  have  been  developed.5 Crich  and  coworkers  have 
developed methods for direct glycosylation to afford a number of 
β-linkages  using mannopyranosyl  sulphoxides  and thioglycoside 
donors.6 Their  method  is  based  on  activation  of  either 
mannopyranosyl  sulphoxides  or  thioglycosides  with Tf2O in the 
presence of a hindered base 2,4,6-tri-tert-butyl pyrimidine to afford 
an in-situ α-mannopyranosyl triflate.7 This triflate then undergoes 
an  SN2-like  reaction  with  an  acceptor  molecule  to  form  a  β-
mannopyranoside.8,9
In  the  present work,  we have  focused on the  synthesis of  β-
(1→2)-linked mannotriose and tetraose containing an anomeric α-
linked phosphate group. Similar structures are found in nature on 
the cell surface of C. albicans and have been suggested to take part 
in the invasion process  of  this fungus.  The  final products  were 
subjected  to  a  detailed  NMR  spectroscopic  and  molecular 
modelling study in  order  to  enhance  the understanding of  their 
conformation and nature in water solutions. 
Results and Discussion
In the synthesis of oligosaccharides, one of the most challenging 
linkages is the β-linkage from mannose. Generally, the  trans-1,2-
glycosylation is difficult with both the kinetic and thermodynamic 
factors  prefering the  formation of  the  corresponding  α-product. 
Due to the anomeric effect, electronegative substituents prefer to 
attain axial configurations at the anomeric position. This is due to 
stabilisation,  as  the  free  electrons  on  the ring oxygen  can  shift 
towards the anti-bonding orbital of the C-O bond (in the case of O-
sugars).  In  addition,  the β-face of mannose is sterically hindered 
due  to  the  axial  substituent  on  the  C-2  carbon.10 The  recently 
developed, highly selective methodologies of Crich and coworkers 
have, however, made these oligosaccharides readily accessible by 
synthetic methods.6-9
Preparation of the monosaccharide building blocks utilized in the 
present work has been addressed previously,  and their syntheses 
will  not  be  discussed here  in  detail.11,12 First,  D-mannose  was 
acetylated  using acetic  anhydride  in  pyridine  and  the  resulting 
peracetylated mannose utilized in a subsequent BF3∙OEt2 promoted 
glycosylation  with  thiophenol  to  give  the  thioglycoside  2 in 
excellent yield  (Scheme 1). Next,  compound  2 was  deacetylated 
under  Zemplén  conditions  to  afford  3 from  which  the  4,6-O-
benzylidene protected monosaccharide 4 was prepared by reaction 
with C6H5CH(OCH3)2 in the presence of a catalytic amount of  p-
TSA. Deprotonation of 4 with NaH followed by addition of BnBr 
afforded the building block  5. For synthesis of building blocks  6 
and  7,  the  3-OH group  of  4 was  first  selectively  protected  by 
forming a dibutyl stannylene between the 3-OH and 2-OH groups 
using Bu2SnO, which then could be selectively benzylated using a 
combination  of  Bu4NBr,  CsF  and  BnBr  to  afford   the  3-OBn 
derivative  6.  Finally,  for  synthesis  of  building block  7,  6 was 
treated  with  NaH  followed  by  addition  of  4-methoxybenzyl 
chloride (Scheme 1).
Synthesis of phosphorylated mannotriose and mannotetraose
The β-coupling from mannose was achieved by the previously 
described methods of Crich by first activating the donors with Tf2O 
in the presence of BSP and the hindered base TTBP at –60 °C to 
yield an in-situ α-triflate, which then was further reacted with an 
acceptor molecule at –78 °C. 7
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Scheme  1.  Synthesis  of  the  monosaccharide  building  blocks.  (i) 
(CH3CO)2O, pyridine, r.t., 2 h (95 %); (ii) BF3∙OEt2, PhSH, CH2Cl2, r.t., 20 
h (90 %); (iii), NaOMe, MeOH, r.t., 18 h (quant); (iv) C6H5CH(OCH3)2, p-
TSA, DMF, 60 °C, 200 mbar, 2 h (91 %); (v) 1. NaH, DMF, 0 °C 0,5 h, 2. 
BnBr,  r.t.,  3  h  (95 %):  (vi)  1.  Bu2SnO,  toluene,  120 °C  reflux,  2  h,  2. 
Bu4NBr, CsF, BnBr, 120 °C reflux, 3 h (85 %); (vii) 1. NaH, DMF, 0 °C,  
0,5 h, 2. 4-methoxybenzyl chloride, r.t., 1 h (95 %)
For preparation of the mannotriose, the disaccharide 8 was first 
prepared from monosaccharides  5 and  6 according to the earlier 
described method.11 The obtained disaccharide was then coupled to 
monosaccharide  6,  again  under  similar conditions,  affording the 
protected trisaccharide 9 in 62% yield (Scheme 2).
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Scheme 2. Synthesis of the trisaccharide 9: (i) TTBP, BSP, Tf2O, CH2Cl2, –
60 °C, 0,5 h → –78 °C, 2h (75 %); (ii) TTBP, BSP, Tf2O, CH2Cl2, –60 °C 
→ –78 °C, 2h (62 %).
For preparation of β-(1→2)-linked mannotetraoses, both linear 3 
+ 1 and convergent 2 + 2 synthetic routes could be considered. It  
has been shown earlier, that a 2 + 2 addition in general gives better 
yields and selectivities compared with the linear route.13 This could 
be  assigned  to  the  helical  character  of  β-(1→2)-linked 
oligomannosides,  evident already at  the trisaccharide stage, with 
the  tetrasaccharide  clearly  adopting  a  helix-like  structure.  This 
prompted us to utilize the 2 + 2 addition route instead of 3 + 1, for  
which the disaccharide 11 had to be synthesized. The synthesis of 
11 was achieved by coupling of the monosaccharides  6 and  7 to 
afford  the  protected  disaccharide  10,  from  which  11 could  be 
prepared  by  oxidative  cleavage  of  the  4-methoxybenzyl  group 
using DDQ in CH2Cl2/H2O. The resulting protected disaccharide 11 
was  then  coupled  with  disaccharide  8 affording  the  protected 
tetrasaccharide 12 in 31 % overall yield over two steps (Scheme 3).
In  general,  several  methodologies  can be utilized to introduce 
phosphate  groups  to  this  type  of  compounds.  The  phosphorus 
bearing  moiety  can  be  added  either  as  a  nucleophile  or  an 
electrophile, depending on the functional groups incorporated. In 
the present study, a preferential route would involve protection of 
the phosphate group with protecting groups similar to those used 
for the carbohydrate coupling partners, allowing the final removal 
of all protecting groups in a single deprotection step.
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Scheme  3.  Synthesis  of  the  tetrasaccharide  12:  (i)   TTBP,  BSP,  Tf2O, 
CH2Cl2, –60 °C, 0,5 h → –78 °C, 2h (57 %); (ii) DDQ, CH2Cl2/H2O, 0 °C, 1 
h (88 %); (iii) TTBP, BSP, Tf2O, CH2Cl2, –60 °C, 0,5 h → –78 °C, 2h (35 
%).
Phosphorylation of similar molecules has been earlier carried out 
by hydrolysis  of  the anomeric thiophenyl  group with NBS in  a 
mixture  of  acetone  and  H2O.11 After  the  hydrolysis,  the  free 
hydroxyl  group  at  the  anomeric  position  can  be  reacted  with 
dibenzyl(N,N-diisopropyl) phosphoramidite in the presence of 1H-
tetrazole, followed by oxidation to phosphate by m-CPBA (Scheme 
4). Unfortunately the yields from this hydrolysis were very low, 
possibly due to the formation of HBr, which might hydrolyse the 
4,6-O-benzylidene  protecting  groups.  Due  to  the  low  yields 
obtained  with  this  methodology,  an  alternative  approach  was 
sought.  Seeberger  has  earlier  published  a  methodology  for 
phosphorylation by using a thioglycoside donor and a phosphate 
acceptor.14 With the protected trisaccharide  9 and tetrasaccharide 
12 already containing a  thioglycoside  functionality,  this seemed 
like  a  reasonable  option.  Accordingly,  the molecules  were then 
reacted with HOPO(OBn)2 in the presence of NIS and TMSOTf or 
TfOH to afford the phosphorylated tri and tetrasaccharides in very 
good  to  excellent  yields.  Unfortunately,  complete  lack  of 
stereoselectivity  was  observed  in  this  reaction,  resulting  in 
essentially 1:1  mixtures  of  the corresponding α  and β products 
(Scheme 5).
After the phosphorylation step, the protecting groups were then 
removed  in  a  single  reaction  in  an  autoclave  reactor.  The 
compounds  were dissolved in  dry methanol  and stirred under 2 
bars  of  H2 gas  overnight  in the presence  of  Pd after which the 
mixture was filtered through celite (Scheme 6).
Characterization by NMR spectroscopy
A number of NMR spectroscopic methods were then utilized for 
characterization  and  verification  of  the  prepared  substrates. 
Determining  the  stereochemistry  at  the  anomeric  position  in 
mannose  by NMR can be  challenging due  to the H-1 and H-2 
protons always occupying either an axial-equatorial (β-mannose) or 
equatorial-equatorial  (α-mannose)  position.  Consequently,  the 
coupling constant is small in both cases and cannot be utilized as a 
reliable measure of  the anomeric configuration.  In  contrast,  the 
chemical shift of the H-5 proton appears at a lower frequency in β-
linked  residues  when  compared  to  the  corresponding  α-
compounds.15 The observed chemical shifts for the trisaccharide 17 
ʹ ʹʹwere  3.86  ppm (H-5),  3.43  (H-5 )  and  3.37  ppm  (H-5 ).  The 
corresponding values for the tetrasaccharide 18 were 3.84 ppm (H-
ʹ ʹʹ ʹʹʹ5), 3.42 ppm (H-5 ), 3.39 ppm (H-5 ) and 3.38 ppm (H-5 ). The 
most reliable indicator of the stereochemistry in mannopyranosides 
is the 1JC-H coupling constant between the anomeric carbon and the 
anomeric proton.   These values are usually ~170 Hz for  the α-
anomer  and  ~160 for  the  β-anomer.16 For  trisaccharide  17,  the 
coupling constants were found to be 173.4 Hz (1JC-1, H-1), 160.5 Hz 
(1J ʹ ʹC-1 -H-1)  and 160.3 Hz (1J ʹʹ ʹʹC-1 -H-1 ).  The  corresponding values for 
tetrasaccharide  18 were 172.1 Hz (1JC-1,  H-1),  159.9 Hz (1J ʹ ʹC-1 -H-1), 
162.0  Hz (1J ʹʹ ʹʹC-1 -H-1 )  and  160.6  Hz  (1J ʹʹʹ ʹʹʹC-1 -H-1 ),  which  all  are  in 
accordance with the literature values.16
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Scheme 4. Phosphorylation of compounds 9 and 12 by method 1: (i) NBS, 
Acetone  /  H2O,  0  °C,  1,5  h  (13:  28  %,  15:  28);  (ii)  1.  dibenzyl(N,N-
diisopropyl)  phosphoramidite,  1H-tetrazole,  CH2Cl2,  0  °C  22  h,  2.  m-
CPBA, –60 °C, 2 h, (14: 41 %, 16: 60 %), α : β = 1 : 1 (14), α : β = 2 : 1 
(16).
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Scheme  5.  Phosphorylation  of  molecules  9 and  12,  method  2.  (i) 
HOPO(OBn)2, NIS, TfOH (9), TMSOTf (15), CH2Cl2, –20 °C → 0 °C, 1 h 
(9), –50 °C → –20 °C, overnight (12) , (14: 42 %, 16: 47 %), α : β ≈ 1 : 1.
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Scheme 6. Deprotection  of molecules 14 and 16. (i): H2, MeOH, Pd/C (10 
% w/w), 2 bar, r.t., overnight (17: 97 %, 18: 67 %)
Another  problem  associated  with  the  NMR  spectroscopic 
characterization of carbohydrates is that most of the carbohydrate 
protons are surrounded by a very similar chemical and electronic 
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environment.  Therefore,  most  of  the  proton  signals  severely 
overlap  in  1H NMR spectra.  1D-TOCSY (1D-Total  Correlation 
SpectroscopY)  can be  utilized to  overcome  these  issues  and to 
distinguish between protons from different residues. This reduces 
the  complexity  of  the  oligosaccharide  1H  NMR  spectrum  to 
monosaccharide level (one residue at a time). After assigning the 
proton and carbon signals of the individual monosaccharide units 
by use of standard NMR-techniques (COSY, HSQC, HMBC), the 
order of residues was then determined from 2D HMBC spectra. In 
order to obtain accurate chemical shifts and coupling constants, the 
1H  NMR  spectra  were  simulated  with  the  PERCH  (PEak 
reseaRCH) NMR simulation software.17
 The  accurate  coupling  constants  acquired  from  the  spectral 
simulations  were  then  used  for  confirming  that  the  individual 
mannose units in the molecules reside in 4C1 conformations (JH-2, H-3 
≈ 3.0 – 3.5 Hz,  JH-3,  H-4 ≈ 9 – 10 Hz,  JH-4,  H-5 ≈ 9 – 10 Hz).  The 
distances  between two axial  protons  in  such conformations  are 
known18 and can thus be used to calculate all other distances from 
the intensities of the signals in NOESY and ROESY NMR spectra.
Conformational studies
Already in the 1970s, empirical force fields were used to predict 
that  β-(1→2)-linked  mannosides  would  form  crumpled 
conformations.19 In previous studies, oligomannosides capped with 
various  alkyl  groups  at  the  reducing  end,  as  well  as  fully 
unprotected oligomannosides, have been shown to attain helical-
like conformations.19,20 A particular goal of the present work was, 
therefore,  to  investigate  the influence  of  the  charged phosphate 
group at the reducing end on the conformational properties of these 
mannosides, in particular by comparison with the fully deprotected 
β-(1→2)-mannotetraose investigated by us recently and shown to 
attain a contorted -helical conformation in solution.20 Thus, both 
the  phosphorylated  mannotriose  and  mannotetraose  were  here 
modelled and molecular dynamics simulations performed on both 
compounds in order to elucidate their behaviour in water solution. 
Obviously, one single conformation does not correctly represent 
the molecule in solution, as the saccharide molecules easily rotate 
and twist around the dihedral angles between the sugar units. Also, 
the remaining chemical bonds may vibrate and twist around energy 
minima to produce a large number of different conformations with 
similar energies. It should be noted that in the NMR experiments, 
an  average  of  all  possible conformations  that the molecule  can 
adopt is recorded in a time scale much longer  than that used in 
molecular  dynamics  simulations  (µs  vs.  fs).  High  energy 
conformations exist only for short periods of time and, therefore, 
correlations  of  these  conformations  are  not  visible  unless 
unrealistically long times are used for NMR experiments.
The  definitions  of  the  dihedral  angles  measured  from  the 
molecular dynamics simulations are illustrated in Figure 2, where 
ϕHn refers to the angle H1n+ʹ-C1n+ʹ-O1n+ʹ-C2n and ψHn refers to the 
angle  C1n+ʹ-O1n+ʹ-C2n-H2n.  The  lower  index  n shows  which 
glycosidic  linkage  the  angles  refer  to  (i.e.,  1,  2  or  3  in  the 
molecules discussed herein). The upper index H will subsequently 
be  omitted,  since  no  other  dihedral  angles  are  considered.  The 
carbon and proton atoms of each residue are numbered from 1 to 6 
and the different residues distinguished by adding a prime symbol 
after the number when progressing from the reducing end towards 
the nonreducing end (the first residue is unprimed, the second has 
one prime, the third has two etc.).
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Figure 2. Definitions of the dihedral angles observed during the molecular 
dynamics simulations.
NOESY and ROESY NMR methods show correlations between 
protons close to each other in space and can thus be used to verify 
the modelled conformation. Unfortunately, in the case of NOESY 
the correlation is often zero for molecules with molecular weights 
of  ~400  –  1500  Da,  i.e.,  from  common  disaccharides  up  to 
pentasaccharide level.19 To overcome these problems, the NOESY 
spectrum of the tetrasaccharide was recorded at 5 °C. The ROESY 
method, however, does not suffer from similar drawbacks and the 
ROESY spectrum for the trisaccharide was recorded at 25 °C.
In  the 2D ROESY spectrum of trisaccharide  17 (Figure 3), the 
correlations  between H1n and H2n+ʹ,  i.e.,  correlations  across  the 
glycosidic  bonds  are  clearly  visible  and  well  separated,  which 
further confirms the correct assignment of the order of residues. 
ʹFurthermore,  a  correlation  between  protons  H1  and  H1  is 
ʹʹobserved. More importantly, correlations between H4 and H1 , as 
ʹʹwell as correlations between H4 and H2  are also visible.  Such 
correlations  between  non-contiguous  residues  indicate  that  the 
structure folds back on itself. Unfortunately, due to overlapping in 
the spectrum, it is impossible to accurately calculate the distances 
ʹʹ ʹʹbetween protons H4 and H1  as well as H4 and H2 .
Figure 3. 2D ROESY spectrum of 17.
Table  1.  Interprotonic  distances  for  molecule  17,  measured  from  the 
modelled structure as well as calculated from NMR data.
Correlation Measured Value (A) Experimental Value (A)
ʹH2, H1 2.4 2.5
ʹH1, H1 3.0 2.8
ʹ ʹʹH2 , H1 2.4 2.4
During  the  molecular  dynamics  simulation,  the  ϕ angles  of 
trisaccharide  17 remain  mostly  around  60  °,  i.e.,  in  gauche 
conformation,  and the  ψ  angles  mostly range  from 0 and 30  ° 
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consistent with ~  eclipsed conformation. Plotting of these angles 
further  reveals  that,  during  the  simulation,  a  number  of  minor 
conformations also appear, although only momentarily. One of the 
low energy conformations, illustrated in Figure 3, has the angles 
ϕ1 = 54.3 °, ψ1 = –1.3 °,  ϕ2 = 44.7 ° and ψ2 = 25.0 °. From this 
conformation, some interprotonic distances were measured and are 
collected in Table 1. The measured values were then compared to 
values  calculated  from  the  intensity  of  the  cross  peaks  in  the 
ROESY  spectrum.  The  arrows  in  Figure  4  correspond  to  the 
correlations marked with identical colors in Figure 3.
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Figure 4. The modelled molecule  17. The colored arrows indicate ROESY 
correlations shown in Figure 3.
In the 2D NOESY spectrum of tetrasaccharide 18 (Figure 5), the 
correlations between protons  H2n and H1n+ʹ  are visible.  In  most 
cases,  however,  the  cross  peaks  overlap  with  the  correlations 
between  H1n and  H2n making  it  impossible  to  calculate  the 
distances with acceptable precision. Correlations between protons 
ʹ ʹH1 and H1  as well as those between H1 and H2  are visible and 
well  separated.  Again,  correlations  can  be  seen  between  non-
ʹʹ ʹʹʹcontiguous residues; between H4 and H2 , between H4 and H1  
ʹ ʹʹʹand between H4  and H2 . Due to overlap of the signals, only the 
ʹ ʹʹʹdistance between H4  and H2  could be calculated with acceptable 
precision.
Table  2.  Interprotonic  distances  for  molecule  18,  measured  from  the 
modelled structure as well as calculated from NMR data.
Correlation Measured Value (A) Experimental Value (A)
ʹH1, H2 3.3 3.3
ʹH1, H1 2.6 2.6
ʹʹH4, H2 3.2 3.0
ʹ ʹʹʹH4 , H2 3.9 3.4[a]
[a] Large deviation probably due to overlapping in the spectrum.
Figure 5. 2D NOESY of spectrum of 18. 
By inspecting the plots of the  ϕ and ψ over the course of the 
molecular  dynamics  simulation,  it  becomes  apparent  that  the 
tetrasaccharide  18 is  somewhat  more  rigid  than  the  analogous 
trisaccharide  17. The glycosidic linkage between the second and 
third mannose unit is, as expected, more rigid than the two terminal 
glycosidic  linkages.  The  ϕ angles  appear  to  remain  between 
approximately 20 and 60 ° and the ψ1 and ψ3 angles between 20 
and 30 °,  respectively.  The ψ2 angle,  however,  seems to have a 
quite significant population on both the positive and negative side, 
around 40 °, indicating that the helical structure can unravel in both 
directions.  One  of  the  low  energy  conformations,  illustrated  in 
Figure 6, contains the angles ϕ1 = 26.2 °, ψ1 = 42.6 °, ϕ2 = 23.4 °, 
ψ2 = 48.8 °,  ϕ3 = 36.3 ° and ψ3 = 23.0 °. Interportonic distances 
were again measured from this structure and the values compared 
to those calculated from the NMR data. The results are presented in 
Table 2. The arrows in Figure 6 correspond to the markings with 
identical colors in Figure 5
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Figure 6. The modelled molecule  18. The colored arrows indicate ROESY 
correlations shown in Figure 4.
Inspection of the measured values for both trisaccharide 17 and 
tetrasaccharide 18 shows good agreement with the experimentally 
determined values, indicating that the modelled structures correctly 
represent  the  actual  conformations  of  the  molecules.  As 
emphasized  previously,  it  should  be  noted  that  the  single  low 
energy conformations depicted in Figures 2 and 4 only represent of 
the molecules at a specific point in time. By combining the data 
from  the  molecular  dynamics  simulation  and  the  NMR 
experiments, it  is evident that  these molecules generally assume 
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conformations similar to those depicted in Figures 2 and 4, while 
even fairly large deviations from these conformations may possibly 
exist for shorter periods of time.
Earlier, it has been suggested that some molecules may be able 
to form more complex structures in solution through intermolecular 
stacking phenoma  of  charged groups  such as the phosphate.  In 
principle,  such  phenomena  can  be  easily  followed  by  NMR-
spectroscopy,  as the chemical shifts of the atoms involved in the 
stacking  should  shift  depending  on  the  concentration  of  the 
molecule in solution. In order to verify or exclude this possibility 
for 17 and 18, NMR samples of both compounds were prepared in 
three different concentrations (0.1 mM, 0.5 mM and 1.0 mM). 1H 
NMR spectra  were  then  recorded  showing  no  changes  in  the 
corresponding chemical shifts. Likewise, in 31P NMR, no changes 
were  visible  in  the NMR spectra  of  the  1.0  mM and 0.5  mM 
samples  with  the  0.1  mM  samples  being  omitted  due  to  the 
unreasonably  long  time  that  would  have  been  required  for 
measuring of the  31P NMR spectra. In  conclusion,  molecules  17 
and 18 are not likely to form any larger aggregates in solution.
Conclusions
In this paper, we have for the first time presented the synthesis of 
phosphate-terminated  β-(1→2)-linked  mannotriose  and 
mannotetraose. Furthermore it is shown that the charged phosphate 
group appears to have very little or no effect on the conformational 
behavior  of  these  molecules  as  compared  to  the  corresponding 
unsubstituted  β-(1→2)-mannans.  Both  the  phosphorylated 
trisaccharide  and  the  corresponding  tetrasaccharide  uptake 
conformations very similar to their neutrally charged analogues. 
The underlying reason becomes evident by inspecting the modelled 
conformations  of  these  compounds,   which  show  that  the 
phosphate group is located outside of the helical structure of the 
carbohydrate oligomers.  Future work with these compounds will 
involve biological evaluations of the synthesized molecules in anti 
C. albicans assays and comparisons of the results obtained with the 
parent  non-phosphorylated  analogues prepared previously at  our 
laboratory.  Such studies are important for gaining information on 
the initiation stages of fungal infections.
Experimental Section
 General  Considerations.  All  reagents  were  purchased  from  Sigma-
Aldrich  and  used  without  further  purification.  Dry  solvents  were  either 
distilled (CH2Cl2 and toluene) or purchased as anhydrous and stored  over  
molecular sieves (DMF and MeOH).  TLC was  performed  on aluminium 
sheets  precoated  with  Silica  gel  60  F254 (Merck)  and  the  spots  were 
visualised  by UV and charred by using a 1:4 solution of H2SO4 in MeOH, 
followed by heating. Column chromatography was carried out using Silica 
gel 60 (0.040 – 0.060 mm, Merck). Optical rotations were measured with a 
Perkin-Elmer  241 polarimeter  equipped  with  a  sodium lamp operating  at 
589 nm, at 24 °C unless mentioned otherwise. HRMS were recorded on a 
Bruker Micro  Q-ToF instrument  with  electrospray ionisation  operating  in 
positive or negative mode. NMR data was recorded using a Bruker Avance 
spectrometer  operating  at  600.13 MHz  for  1H,  150.90 MHz for  13C and 
202.47 MHz for  31P. NOESY spectra  of tetrasaccharide  18 were recorded 
using a Bruker Avance spectrometer with a proton resonance frequency of 
700.17 MHz.  The complete  assignment of proton and carbon spectra  was 
carried  out  by  using  a  standard  set  of NMR experiments,  1H NMR,  13C 
NMR,  31P  NMR,  DQF-COSY,  HSQC  (both  coupled  and  decoupled), 
HMBC and, as previously mentioned, 1D-TOCSY was used to simplify the 
1H NMR spectra. In  addition,  2D ROESY (for the trisaccharide)  and 2D 
NOESY (for the tetrasaccharide)  experiments  were performed to  assist  in 
the conformational analysis.  Chemical shifts are expressed on the δ (ppm) 
scale,  calibrated  using the signals  from  TMS (tetramethylsilane,  δH = 0.0 
ppm,  δC =  0.0  ppm)  or  HOD  (δH =  4.79  ppm).  31P NMR spectra  were 
calibrated  using  an  external  standard,  a  0.0485  M  solution  of  PPh3 in 
[d6]acetone,  (δP =  –17.90 ppm).    The  modelling  of  the  molecules  was 
carried  out using Maestro,21 and the energy minimizations  and molecular 
dynamics simulations with Impact.22 First,  the models were drawn, simply 
in  order  to  create  the  atoms  and  bonds,  after  which  an iterative  energy 
minimization was performed for obtaining a starting point for the dynamics 
simulation. The acquired models were visually inspected in order to verify  
that  they  were  realistic.  The  minimizations  and  molecular  dynamics  
simulations  were  performed  using  the  OPLS_2005  force  field  with  a 
constant  dielectricity  80  (the  relative  permeability  for  water).  The 
calculations  were  carried  out  with  continuum  solvation  with  implicit  
solvent using a surface generalized Born model. The algorithm used for the 
minimization  was a truncated  Newton,  which  is  an effective  method  for  
acquiring  optimized  structures.  After  the  minimization,  a  molecular 
dynamics simulation was performed in 1 000 000 steps, each 2 fs to obtain 
a total simulation time of 2 ns. The force field, electrostatic treatment and 
solvation model were all the similar to those used for the minimization. The 
equations of motion were integrated using the r-RESPA algorithm, and the  
structure  was  stored  every  fifth  step.  From  the  molecular  dynamics 
simulations,  the  dihedral  angles  between  the  mannose  units  were  then 
recorded  and  plotted  in  order  to  provide  a  model  for  flexibility  of  the 
model.  The low  energy  conformations  obtained  by molecular  modelling 
were then compared with the NMR data  of these compounds in order  to 
verify that the simulations correctly represent the molecular structures.
General procedure for β-mannosylation.  To a solution  of the donor  (1 
equivalent)  in dry CH2Cl2 (5 ml/0.1  mmol  donor)  under argon at –60 °C 
(acetone dry ice) was added pre-activated 4 Å molecular sieves, BSP (1.20 
equivalents),  TTBP  (1.5  equivalents)  and  Tf2O  (1.3  equivalents).  The 
reaction  mixture  was  stirred  for  30  minutes  until  the  activation  was 
complete  (confirmed  by  TLC),  after  which  1-octene  (1  equivalent)  was 
added and the  reaction  mixture  was stirred  for  another  15  minutes.  The 
reaction  mixture was then cooled  down  to –78 °C  and a  solution  of the 
acceptor  (1.15  equivalents)  in  dry  CH2Cl2 (1  ml/0.1  mmol)  was  added 
dropwise. The reaction mixture was stirred for 2 h, at –78 °C and, after the 
reaction  was  complete,  it  was  quenched  by  adding  triethylphosphite  (3 
equivalents)  and stirred for 1 h. The reaction mixture was then warmed to 
room  temperature  and diluted  with  CH2Cl2 (30  ml/100 mg)  and washed 
with a saturated solution of NaHCO3 in H2O (30 ml/100 g). The water layer 
was extracted with CH2Cl2 (2 × 30 ml/100 mg) after which the combined 
organic  layers  were  washed  with  brine  (30 ml/100 mg)  and  dried  over 
Na2SO4. The solvent  was removed and the crude product was purified by 
column chromatography to yield the β-coupled product.
General  procedure  for  hydrogenolysis  of  benzyl  and  benzylidene 
protecting groups. To a solution  of the protected  sugar molecule  in dry 
MeOH  (1.5  ml/10  mg  protected  sugar)  was  added  Pd/C  10%  w/w  (2 
equivalents by mass) and the mixture was stirred in an autoclave under H2 
(2 bar) overnight. The reaction mixture was then filtered through celite and 
evaporated to dryness to yield the corresponding unprotected product.
Phenyl-2,3-di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→2)-
3-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→2)-3-O-benzyl-
4,6-O-benzylidene-1-thio-α-D-mannopyranoside  (9). Synthesized  from 
donor  8  (200  mg,  0.2  mmol)  and  acceptor  6  (107  mg,  0.24  mmol) 
according to the general procedure for β-mannosylation. The product was 
purified  by column chromatography (hexane : EtOAc 2 : 1,  Rf = 0.45) to 
yield  9 as a white  foam.  Yield: 166 mg (62%).  [α]D  = –  51,5 ° (c = 1.0 
CH2Cl2, 24 °C). 1H NMR (600.13 MHz, CDCl3, 25 °C): δ = 7.25 – 6.90 (m, 
40 H, arom. H), 5.60 (s, 1 H, 4,6-OCHʹPh), 5.57 (s, 1 H, 4,6-OCHPh), 5.51 
(d, 1 H, JH-1, H-2 = 1.4 Hz, H-1), 5.37 (s, 1 H, 4,6-OCHʹʹPh), 5.10 (d, 1 H, JH-
ʹʹ ʹʹ1 ,  H-2 ʹʹ = 0.5 Hz, H-1 ), 4.97 and 5.72 (each d, each 1 H, J = –12.5 Hz, 2-
OCH2Ph), 4.82 and 4.77 (each d, each 1 H, J ʹ = –12.6 Hz, 3 -OCH2Ph), 4.67 
and 4.62 (each d, each 1 H, J = –12.2 Hz, 3-OCH2Ph), 4.65 (d, 1 H, J ʹ ʹH-1 , H-2  
ʹ= 0.1 Hz, H-1 ), 4.56 (dd, 1 H, JH-2, H-3 = 3.0 Hz, H-2), 4.46 and 4.43 (each d, 
6
each 1 H, J ʹʹ = –11.6 Hz, 3 -OCH2Ph), 4.45 (dd, 1 H, J ʹʹ ʹʹH-2 , H-3  = 3.2 Hz, H-
ʹʹ2 ), 4.36 (dd, 1 H, J ʹ ʹH-2 , H-3 ʹ = 3.1 Hz, H-2 ) 4.34 (ddd, 1 H, JH-5, H-6a = 4.9 Hz, 
JH-5, H-4 = 9.2 Hz, JH-5, H-6b = 10.2 Hz, H-5), 4.33 (dd, 1 H, J ʹʹ ʹʹH-6 a, H-5  = 4.9 Hz, 
J ʹʹ ʹʹH-6 a, H-6 b ʹʹ = –10.5 Hz, H-6 a), 4.31 (dd, 1 H, J ʹ ʹH-6 a, H-5  = 4.8 Hz, J ʹ ʹH-6 a, H-6 b = –
ʹ10.0 Hz, H-6 a), 4.23 (dd, 1 H, JH-6a,  H-6b = –10.3 Hz, H-6a), 4.22 (dd, 1 H, 
J ʹʹ ʹʹH-4 , H-5  = 9.2 Hz, J ʹʹ ʹʹH-4 , H-3 ʹʹ = 9.9 Hz, H-4 ), 4.06 (dd, 1 H, J ʹ ʹH-4 , H-5  = 9.3 Hz, 
J ʹ ʹH-4 ,H-3 ʹ = 9.8 Hz, H-4 ), 3.99 (dd, 1 H, JH-4, H-3 = 10.1 Hz, H-4), 3.98 (dd, 1 H, 
H-3), 4.97 (dd, 1 H, J ʹʹ ʹʹ6 b, 5 ʹʹ = 10.1 Hz, H-6 b), 3.77 (dd, 1 H, JH-6b, H-5 = 10.2 
Hz, H-6b), 3.72 (dd, J ʹ ʹH-6 b, H-5 ʹ ʹ = 10.1 Hz, H-6 b), 3.64 (dd, 1 H, H-3 ), 3.55 
ʹʹ ʹʹ ʹ(dd, 1 H, H-3 ), 3.43 (ddd, 1 H, H-5 ), 3.33 (ddd, 1 H, H-5 ) ppm.
13C NMR (150.9 MHz, CDCl3, 25 °C): δ = 139.4 – 126.0 (arom. C), 103.0 
ʹʹ(C-1 ),  102.0  (4,6-OCHPh),  101.6  (4,6-OCʹʹHPh),  101.3  (4,6-OCʹHPh), 
ʹ ʹʹ ʹ ʹʹ98.5 (C-1 ), 85.6 (C-1), 79.3 (C-3 ), 79.0 (C-4), 78.2 (C-4 ), 78.1 (C-4 ), 
ʹ ʹʹ ʹ76.2 (C-2  and C-2 ), 75.7 (C-3 ), 74.9 (2-OCH2Ph), 74.8 (C-2), 74.6 (C-3), 
ʹʹ72.2 (3 -OCH2Ph), 71.8 (3-OCH2 ʹPh), 71.0 (3 -OCH2 ʹʹPh), 68.7 (C-6 ), 68.6 
ʹ ʹʹ ʹ(C-6 and C-6 ), 67.9 (C-5 ), 67.8 (C-5 ), 65.2 (C-5) ppm.
HRMS:  m/z calcd.  for  C73H73O15SNa  [M+  Na]+:  1243.4490;  Found 
1243.4502
2,3-Di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→2)-3-O-
benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→2)-3-O-benzyl-4,6-
O-benzylidene-D-mannopyranose  (13). A  solution  of  9  (255  mg,  1 
equivalent) in 5 ml of a 50:1 mixture of acetone : H2O was cooled on an ice 
bath and NBS (69 mg, 2 equivalents)  was added and the reaction mixture 
was  stirred  ad  0  °C  for  30  min  after  which  additional  NBS (35  mg,  1 
equivalent)  was added and the reaction  mixture  was again stirred  for  30 
min.  Additional  NBS (69 mg 2 equivalents)  was added  and the reaction 
mixture was stirred for 30 min after which solid  Na2S2O3 was added until 
the yellow color disappeared. The solvent was evaporated and the resulting 
oil  was dissolved  in 50 ml  CH2Cl2 and washed with  3 × 20 ml H2O and 
dried over Na2SO4 after which the solvent was removed. The crude product 
was purified by column chromatography (hexane : EtOAc 1 : 1, Rf = 0.36) 
to yield 13 as a white foam. Yield: 61 mg (28%). Due to the complexity of  
the  NMR spectra  caused  by a  mixture  of  anomers,  the  spectra  were  not 
fully assigned.
HRMS:  m/z calcd.  for  C67H68O16Na  [M  +  Na]+:  1151.4405;  Found 
1151.4401
[2,3-Di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→2)-3-O-
benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→2)-3-O-benzyl-4,6-
O-benzylidene-α-D-mannopyranosyl]  dibenzylphosphate  (14). Method 
1: To a solution of 13 (40 mg, 1 equivalent) in dry CH2Cl2 under argon was 
added  1H-tetrazole  (9.3  mg,  3.8  equivalents)  after  which  the  reaction 
mixture  was  cooled  down  to  0  °C.  Dibenzyl(N,N-diisopropyl) 
phosphoramidite (30 µl, 2.5 equivalents) was added after which the reaction 
mixture was allowed to warm up to room temperature and was stirred for 
22 h. The reaction mixture was then cooled to –60 °C and 20 mg m-CPBA 
was added. The reaction mixture was stirred at 0 °C for 1.5 h and at room 
temperature for 2 h after which it was diluted with 40 ml CH2Cl2, washed 
with 2 × 15 ml of a saturated solution of Na2S2O3 in H2O, 2 × 15 ml of a 
saturated solution of NaHCO3 in H2O and 2 × 10 ml H2O. The organic layer 
was purified by column chromatography (hexane : EtOAc 1 : 1, Rf = 0.57) 
to yield 14 as a white foam. Yield of α-product: 20 mg (41%). [α]D = – 51,7 
° (c = 0.1 CH2Cl2, 24 °C).
Method 2: To a solution of  9 (140 mg, 1 equivalent)  in 3 ml dry CH2Cl2 
under  argon  was added  HOPO(OBn)2 (94.3  mg,  3  equivalents)  and 4  Å 
molecular sieves. The reaction mixture was cooled to –20 °C and NIS (30.5 
mg, 1.2 equivalents) and TfOH, (2.5 µl, 0.12 equivalents) were added. The 
reaction  mixture was stirred  at 0 °C  for 1 h after which the reaction  was 
quenched by adding 0.5 ml pyridine. The reaction mixture was diluted with 
20 ml CH2Cl2 and washed with 2 × 15 ml of a saturated solution of Na2S2O2 
in H2O, 2 × 15 ml of a saturated solution of NaHCO3 in H2O and 1 × 15 ml 
H2O.  The  organic  layer  was  dried  over  Na2SO4 and  the  solvent  was 
removed.  The  crude  product  was  purified  by  column  chromatography 
(hexane : EtOAc 1 : 1) to yield 14 as a white foam. Yield of α-product: 64.2 
mg (42 %). 1H NMR (600.13 MHz, CDCl3, 25 °C): δ = 7.60 – 7 (m, 45 H, 
arom. H), 5.60 (s, 1 H, 4,6-OCHʹʹPh), 5.58 (dd, 1 H, JH-1, H-2 = 1.5 Hz, JH-1, P 
= 6.2 Hz), 5.45 (s, 1 H, 4,6-OCHʹPh), 5.33 (s, 1 H, 4,6-OCHPh), 5.08 and 
5.03 [each dd, each, 1 H, J = –11.9 Hz, JCH2a,P = 8.9 Hz, JCH2b,P = 8.2 Hz, 
PO(OCH2Ph)], 5.02 and 4.99 [each dd, each, 1 H, J = –11.8 Hz, JCH2a,  P = 
13.6 Hz, JCH2b,P = 9.6 Hz, PO(OCH2Ph)], 5.00 (d, 1 H, J ʹʹ ʹʹH-1 , H-2  = 0.1 Hz, H-
ʹʹ1 ), 4.91 and 4.69 (each d, each 1 H, J ʹʹ = –12.5 Hz, 2 -OCH2Ph), 4.83 and 
4.78 (each d, each 1 H, J ʹ = –12.5 Hz, 3 -OCH2Ph), 4.60 and 4.56 (each d, 
each 1 H, J = –12.2 Hz, 3-OCH2 ʹPh), 4.47 (s, 1  H, H-1 ), 4.45 and 4.42 
(each d, each 1 H, J ʹʹ =  –11.7 Hz, 3 -OCH2Ph), 4.39 (dd, 1 H, J ʹʹ ʹʹH-2 , H-3  = 3.2 
ʹʹHz, H-2 ), 4.34 (dd, 1 H, J ʹʹ ʹʹH-6 a, H-5  = 4.8 Hz, J ʹʹ ʹʹH-6 a.  H-6 b ʹʹ = –10.4 Hz, H-6 a), 
4.29 (d, 1 H, J ʹ ʹ ʹH-2 , H 3 ʹ = 3.1 Hz, H-2 ), 4.26 (dd, 1 H, J ʹ ʹH-6 a, H-5  = 4.8 Hz, J ʹH-6 a, H-
ʹ6 b ʹ = –10.2 Hz, H-6 a), 4.22 (dd, 1 H, J ʹʹ ʹʹH-4 , 5  = 9.2 Hz, J ʹʹ ʹʹH-4 , H-3  = 9.8 Hz, H-
ʹʹ4 ), 4.15 (dd, 1 H, JH-2, H-3 = 3.3 Hz, H-2), 4.02 (dd, 1 H, J ʹ ʹH-4 , H-5  = 9.4 Hz, JH-
ʹ ʹ4 , H-3 ʹ = 9.7 Hz, H-4 ), 3.99 (dd, 1 H, JH-6a,  H-5 = 4.9 Hz, JH-6a,  H-6b = –10.3 Hz, 
H-6a), 3.97 (dd, 1 H, J ʹʹ ʹʹH-6 b, 5 ʹʹ = 10.2 Hz, H-6 b), 3.85 (dd, 1 H, JH-4,H-5 = 9.0 
Hz, JH-4,H-3 = 10.2 Hz, H-4), 3.84 (ddd, 1 H, JH-5,  H-6b = 10.1 Hz, H-5), 3.83 
(dd, 1 H, H-3), 3.67 (dd, 1 H, J ʹ ʹH-6 b, H-5 ʹ = 10.1 Hz, H-6 b), 3.60 (dd, 1 H, H-
ʹ ʹʹ ʹʹ6b), 3.59 (dd, 1 H, H-3 ), 3.53 (dd, 1 H, -3 ), 3.41 (ddd,  1 H, H-5 ), 3.24 
ʹʹ(ddd, 1 H, H-5 ) ppm.
13C NMR (150.9 MHz, CDCl3, 25 °C): δ = 139.3 – 135.2(arom. C), 103.0 
ʹʹ(C-1 ),  101.9  (4,6-OCʹHPh),  101.6  (6,6-OCHPh),  101.3  (4,6-OCʹʹHPh), 
ʹ99.6 (C-1 ), 95.7 (2JC-1,P ʹʹ ʹ ʹʹ = 5.7 Hz, C-1), 79.2 (C-3 ), 78.1 (C-4, C-4 , C-4 ), 
ʹ ʹʹ ʹ76.2 (C-2 ), 76.0 (C-2 ), 75.5 (C-3 ), 74.9 (2-OCH2Ph), 73.7   (3JC-2,P = 9.9 
ʹʹHz,  C-2),  73.5  (C-3),  72.1  (3 -OCH2Ph),  71.9  (3-OCH2 ʹPh),  71.1  (3 -
OCH2Ph),  69.9  [2JC,P =  6.1  Hz,  PO(OCH2Ph)],  69.8  (2JC,P =  6.1  Hz, 
PO(OCH2 ʹʹ ʹ ʹʹ ʹPh)], 68.7 (C-6 ), 68.5 (C-6 ), 68.3 (C-6), 67.9 (C-5 ), 67.6 (C-5 ), 
65.5 (C-5) ppm.
31P NMR (242.9 MHz, CDCl3, 25 °C): δ = –2.88 ppm.
HRMS:  m/z calcd.  for  C81H81O19PNa  [M+  Na]+:  1411.5007;  Found 
1411.5025
β-D-Mannopyranosyl-(1→2)-β-D-mannopyranosyl-(1→2)-α-D-
mannopyranosylphosphate  (17). Synthesized  from  14  (22  mg,  0.016 
mmol) according to the general procedure for hydrogenolysis of benzyl and 
benzylidene protecting  group. Filtration  through celite  with water yielded 
the product as a colorless oil. Yield: 9 mg (97%). [α]D  = – 13 ° (c = 0.01 
H2O, 24 °C). 1H NMR (600.13 MHz, CDCl3, 25 °C): δ = 5.45 (dd, 1 H,  JH-1, 
H-2 = 1.5 Hz, JH-1, P = 7.9 Hz, H-1), 4.96 (d, 1 H, J ʹ ʹH-1 , H-2 ʹ = 0.2 Hz, H-1 ), 4.88 
(d, 1 H,   J ʹʹ ʹʹH-1 , H-2 ʹʹ = 0.5 Hz, H-1 ), 4.32 (dd, 1 H, J ʹ ʹH-2 , H-3 ʹ = 3.4 Hz, H-2 ), 
4.18 (dd, 1 H, J ʹʹ ʹʹH-2 , H-3 ʹʹ = 3.3 Hz, H-2 ), 4.15 (dd, JH-2, H-3 = 3.1 Hz, H-2), 4.01 
(dd, JH-3,  H-4 = 9.8 Hz, H-3), 3.93 (dd, 2 H, J ʹ ʹH-6 a,  H-5  = 2.1 Hz, J ʹ ʹH-6 a,  H-6 b = –
11.9 Hz, J ʹʹ ʹʹH-6 a,  H-5  = 2.2 Hz, J ʹʹ ʹʹH-6 a,  H-6 b  ʹ ʹʹ= –12.6 Hz, H-6 a and H-6 a), 3.89 
(dd, 1 H, JH-6a, H-5 = 2.1 Hz, J ʹʹ ʹʹH-6 a, H-6 b = –12.4 Hz, H-6a), 3.86 (ddd, JH-5, H-6b = 
5.6 Hz, JH-5, H-4 = 9.8 Hz, H-5), 3.77 (dd, 1 H, H-6b), 3.75 (dd, 1 H, J ʹ ʹH-6 b, H-5  
ʹ= 5.9 Hz, H-6 b), 3.73 (dd, 1 H, J ʹʹ ʹʹH-6 b, H-5 ʹʹ = 6.4 Hz, H-6 b), 3.70 (dd, 1 H, JH-
ʹ ʹ3 , H-4 ʹ = 9.9 Hz, H-3 ), 3.64 (dd, 1 H, J ʹʹ ʹʹH-3 , H-4 ʹʹ = 9.9 Hz, H-3 ), 3.61 (each dd, 
each 1 H, J ʹ ʹH-4 , H-5 ʹ = 9.7 Hz, H-4 and H-4 ), 3.57 (dd, 1 H, J ʹʹ ʹʹH-4 , H-5  = 9.8 Hz, 
ʹʹ ʹ ʹʹH-4 ), 3.43 (ddd, 1 H, H-5 ), 3.37 (ddd, 1 H, H-5 ) ppm. 
13C NMR (150.9 MHz, CDCl3 ʹʹ ʹ, 25 °C): δ = 101.0 (C-1 ), 98.9 (C-1 ), 92.9 
(2JC-1, P = 4.0 Hz, C-1), 78.8 (3JC-2, P ʹ ʹʹ = 6.6 Hz, C-2), 78.7 (C-2 ), 76.2 (C-5 ), 
ʹ ʹʹ ʹ ʹʹ76.1 (C-5 ), 72.9 (C-5), 72.8 (C-3 ), 72.1  (C-3 ), 70.4 (C-2 ), 69.1 (C-3), 
ʹ ʹʹ ʹʹ ʹ67.3 and 66.9 (C-4 and C-4 ), 66.7 (C-4 ), 61.0 (C-6 ), 60.7 (C-6 ), 60.5 (C-
6) ppm.
31P NMR (242.9 MHz, CDCl3, 25 °C): δ = 1.46 ppm.
HRMS: m/z calcd. for C18H32O19P [M - H]-: 853.1276; Found 853.1252
Phenyl-2-O-(4-methoxybenzyl)-3-O-benzyl-4,6-O-benzylidene-β-D-
mannopyranosyl-(1→2)-3-O-benzyl-4,6-O-benzylidene-1-thio-α-D-
mannopyranoside (10). Synthesized from donor  7 (500 mg 0.876 mmol) 
and acceptor 6 (455 mg 1.01 mmol) according to the general procedure for  
β-mannosylation.  The  crude  product  was  purified  by  column 
chromatography (hexane : EtOAc 2 : 1,  Rf = 0.45) Yield: 455 mg (57%). 
[α]D = – 52,5 ° (c = 1.0 CH2Cl2, 24 °C). 1H NMR (600.13 MHz, CDCl3, 25 
°C): δ = 7.75 – 7.20 (m, 29 H, arom. H), 5.59 (s, 1 H, 4,6-OCHʹPh), 5.52 (s, 
1 H, 4,6-OCHPh), 5.50 (d, 1 H, JH-1, H-2 = 1.5 Hz, H-1), 4.97 and 4.89 (each 
d, each 1 H, J ʹ = –11.8, 2 -OCH2Ph), 4.80 and 4.75 (each d, each 1 H, J = –
7
12.1 Hz, 3-OCH2Ph), 4.67 and 4.59 (each d, each 1 H, J ʹ = –12.5 Hz, 3 -
OCH2Ph), 4.61 (d, 1 H, J ʹ ʹH-1 , H-2 ʹ = 0.9 Hz, H-1 ), 4.51 (dd, 1 H, JH-2, H-3 = 3.2 
Hz, H-2), 4.33 (ddd, 1 H, JH-5, H-6a = 4.8 Hz, JH-5, H-4 = 9.5 Hz, JH-5, H-6b = 10.2 
Hz, H-5), 4.24 (dd, 2 H, JH-6a, H-6b = –10.2 Hz, J ʹ ʹH-6 a, H-5  = 4.9 Hz, J ʹ ʹH-6 a, H-6 b = –
10.4 Hz, H-6a and H-6b), 4.23 (dd, 1 H, J ʹ ʹH-4 , H-5  = 9.3 Hz, J ʹ ʹH-4 , H-3  = 9.9 Hz, 
ʹH-4 ), 4.17 (dd, 1 H, JH-4, H-3 = 10.0 Hz, H-4), 3.98 (dd, 1 H, H-3), 3.96 (dd, 
1 H, J ʹ ʹH-2 , H-3 ʹ = 3.2 Hz, H-2 ), 3.82 (dd, J ʹ ʹH-6 b, H-5 ʹ = 10.1 Hz, H-6 b), 3.79 (dd, 
1 H, H-6b), 3.73 (s, 3 H, OCH3 ʹ), 3.57 (dd, 1 H, H-3 ), 3.29 (ddd, 1 H, H-5) 
ppm.
13C NMR (150.9 MHz, CDCl3, 25 °C): δ = 159.1 – 113.5 (arom. C), 101.7  
(4,6-OCHPh), 101.4 (4,6-OCʹ ʹHPh), 99.8 (C-1 ), 86.4 (C-1), 78.7 (C-4), 78.4 
ʹ ʹ ʹ ʹ(C-4 ), 77.5 (C-3 ), 76.1 (C-2), 75.4 (C-2 ), 74.3 (C-3), 74.2 (2 -OCH2Ph), 
ʹ72.2  (3 -OCH2Ph), 71.4  (3-OCH2 ʹ ʹPh), 68.6 (C-6), 68.5 (C-6 ), 67.7 (C-5 ), 
65.4 (C-5), 55.2 (OCH3) ppm.
HRMS:  m/z calcd.  for  C54H54O11SNa  [M  +  Na]+:  933.3285;  Found 
933.3228;  m/z calcd.  for  C54H58O11SN  [M  +  NH4]+:  928.3731;  Found 
928.3634.
Phenyl-3-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→2)-3-O-
benzyl-4,6-O-benzylidene-1-thio-α-D-mannopyranoside (11).  A solution 
of 10 (200 mg, 1 equivalent) in 3 ml CH2Cl2 was cooled down to 0 °C and a 
suspension  of  DDQ  (74  mg,  1.5  equivalents)  in  3  ml  H2O  was  added 
dropwise.  The reaction  mixture was stirred  for 1 h at 0 °C after which it 
was diluted with 25 ml CH2Cl2 and washed with 2 × 25 ml of a saturated 
solution of NaHCO3 in H2O. The water layer was extracted with 2 × 25 ml 
CH2Cl2, dried  over Na2SO4 and evaporated  to dryness.  The crude product 
was purified by column chromatography (hexane : EtOAc 2 : 1) to yield the 
11 as a white foam. Yield: 153 mg (88%). NMR spectra are in accordance  
with those published previously.14
Phenyl-2,3-di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→2)-
3-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→2)-3-O-benzyl-
4,6-O-benzylidene-β-D-mannopyranosyl-(1→2)-3-O-benzyl-4,6-O-
benzylidene-1-thio-α-D-mannopyranoside (12). Synthesized from donor 8 
(290 mg, 0.33 mmol) and acceptor  11 (300 mg, 0.38 mmol) according to 
the general procedure for β-mannosylation. The crude product was purified  
by  column chromatography (hexane  : EtOAc 2 :  1,  Rf (R kursivt  på  alla 
platser)= 0.50). Yield: 182 mg (35 %). [α]D = – 62,0 ° (c = 1.0 CH2Cl2, 24 
°C).  1H NMR (600.13 MHz,  CDCl3,  25  °C):  δ = 7.75 –  7.00 (m,  50 H, 
arom. H), 5.57 (s, 1 H, 4,6-OCHʹʹPh), 5.54 (s, 1 H, 4,6-OCHPh), 5.49 (d, 1 
H, JH-1,  H-2 = 1.3 Hz,  H-1), 5.44  (s, 1 H, 4,6-OCHʹPh),  5.40 (s, 1 H, 4,6-
OCHʹʹʹ ʹʹPh), 5.27 (s, 1 H, H-1 ), 5.07 (d, 1 H, J ʹʹʹ ʹʹʹH-1 , H-2 ʹʹʹ = 0.1 Hz, H-1 ), 5.00 
and 4.84 (each d, each 1 H, J ʹʹʹ = –12.6 Hz, 2 -OCH2Ph), 4.70 (s, 2 H, 3-
OCH2Ph), 4.68 and 4.61 (each d, each 1 H, J ʹ = –12.4 Hz, 3 -OCH2Ph), 4.68 
ʹ(s, 1 H, H-1 ), 4.62 and 4.44 (each d, each 1 H, J ʹʹ = –11.9 Hz, 3 -OCH2Ph), 
4.54 (d, 1 H, J ʹʹ ʹʹH-2 , H-3 ʹʹ = 3.0 Hz, H-2 ), 4.53 (dd, 1 H, JH-2, H-3 = 3.1 Hz, H-2), 
4.50 and 4.40 (each d, each 1 H, J ʹʹʹ = –11.8 Hz, 3 -OCH2Ph), 4.48 (d, 1 H, 
J ʹ ʹH-2 , H-3 ʹ = 3.4 Hz, H-2 ), 4.41 (dd, 1 H, J ʹʹʹ ʹʹʹH-2 , H-3 ʹʹʹ = 3.3 Hz, H-2 ), 4.33 (dd 
and ddd, 2 H, J ʹʹ ʹʹH-6 a, H-5  = 4.8 Hz, J ʹʹ ʹʹH-6 a, H-6 b = –10.2 Hz, JH-5, H-6a = 5.0 Hz, JH-5, 
H-4 = 9.2 Hz, JH-5, H-6b ʹʹ = 10.2 Hz, H-6 a and H-5), 4.31 (dd, 1 H, J ʹ ʹH-6 a, H-5  = 4.8 
Hz, J ʹ ʹH-6 a,  H-6 b = –10.3 Hz), 4.23 (dd, 1 H, JH-6a,  H-6b = –10.3 Hz, H-6a), 4.19 
(dd and dd, 2 H, J ʹʹʹ ʹʹʹH-4 , H-5   = 9.3 Hz, J ʹʹʹ ʹʹʹH-4 , H-3  = 9.9 Hz, J ʹʹʹ ʹʹʹH-6 a, H-5  = 4.9 Hz, JH-
ʹʹʹ ʹʹʹ6 a, H-6 b ʹʹʹ ʹʹʹ = –10.3 Hz, H-4  and H-6 a), 4.06 (dd, 1 H, J ʹʹ ʹʹH-4 , H-5  = 9.3 Hz, J ʹʹH-4 , 
ʹʹH-3 ʹʹ = 9.8 Hz, H-4 ), 3.99 (dd, 1 H, JH-4, H-3 = 9.9 Hz, H-4), 3.97 (dd, 1 H, H-
3), 4.93 (dd, 1 H, J ʹ ʹH-4 , H-5  = 9.3 Hz, J ʹ ʹH-4 , H-3 ʹ = 9.8 Hz, H-4 ), 3.87 (dd, 1 H, 
J ʹʹʹ ʹʹʹH-6 b, H-5 ʹʹʹ = 10.1 Hz, H-6 b), 3.78 (dd, 1 H,  J ʹʹ ʹʹH-6 b, H-5 ʹʹ = 10.1 Hz, H-6 b), 4.77 
(dd, 1 H, J ʹ ʹH-6 b, H-5 ʹ = 10.1 Hz, H-6 b), 3.74 (dd, 1 H, H-6b), 3.66 (dd, 1 H, H-
ʹ ʹʹ ʹ ʹʹ ʹʹ3 ), 5.54 (dd, 1 H, H-3 ), 3.53 (dd, 1 H, H-3 ), 3.43 (ddd, 1 H, H-5 ), 3.36 
ʹ ʹʹʹ(ddd, 1 H, H-5 ), 3.32 (ddd, 1 H, H-5 ) ppm.
13C NMR (150.9 MHz, CDCl3, 25 °C): δ = 139.4 – 126.1 (arom. C), 103.4  
ʹʹʹ(C-1 ), 102.1 (4,6-OCHPh), 102.0 (4,6-OCʹ ʹʹHPh), 101.8 (C-1 ), 101.5 (4,6-
OCʹʹʹHPh),  101.3 (4,6-OCʹʹ ʹHPh), 99.1 (C-1 ), 85.7 (C-1), 79.1 (C-4), 79.0 
ʹʹʹ ʹ ʹʹ ʹ ʹʹ ʹʹ ʹ(C-3 ), 78.4 (C-4 ), 78.3 (C-4 ), 78.2 (C-4 ), 77.0 (C-3 ), 76.3 (C-3 ), 76.1 
ʹʹ ʹʹʹ ʹʹʹ(C-2 ), 76.0 (C-2 ), 75.5 (C-2), 74.7 (2 -OCH2 ʹPh), 74.5 (C-3), 74.0 (C-2 ), 
ʹʹʹ72.2  (3 -OCH2Ph),  72.1  (3-OCH2 ʹPh),  71.3  (3 -OCH2 ʹʹPh),  70.9  (3 -
OCH2 ʹʹʹ ʹʹ ʹ ʹʹPh), 68.8 (C-6 ), 68.7 (C-6 , C-6 ), 68.6 (C-6), 68.0 (C-5 ), 67.9 (C-
ʹ ʹʹʹ5 ), 67.5 (C-5 ), 65.2 (C-5) ppm.
HRMS:  m/z calcd.  for  C93H92O20SNa  [M  +  Na]+:  1583.5800;  Found 
1583.5812.
2,3-Di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→2)-3-O-
benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→2)-3-O-benzyl-4,6-
O-benzylidene-β-D-mannopyranosyl-(1→2)-3-O-benzyl-4,6-O-
benzylidene-D-mannopyranose  (15). A  solution  of  12 (250  mg,  1 
equivalent) in 5 ml of a 6:1 mixture of acetone : H2O was cooled on an ice 
bath and NBS (60 mg, 2 equivalents)  was added and the reaction mixture 
was stirred  for 30 min.  Additional NBS (30 mg,  1 equivalent)  was added 
and the reaction mixture was again stirred for 30 min after which additional 
NBS (30 mg, 1 equivalent) was added and the reaction mixture was stirred 
for 30 min. The reaction  was quenched by adding solid Na2S2O3 until  the 
yellow color had disappeared. The solvent was evaporated and the residue 
was  dissolved  in  50 ml  CH2Cl2 and washed  with  2  ×  20 ml  H2O.  The 
organic layer was dried over Na2SO4 and evaporated to dryness. The crude 
product was purified by column chromatography (hexane : EtOAc 1 : 1, Rf 
= 0.38)  to  yield  15 as  a  white  foam.  Yield  (62 mg  (28%).  Due to  the 
complexity of the NMR spectra caused by a mixture of anomers, the spectra 
were not fully assigned.
HRMS:  m/z calcd.  for  C87H92O21N  [M  +  NH4]+:  1486.6162;  Found 
1486.6174.
[2,3-Di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→2)-3-O-
benzyl-4,6-O-benzylidene-β-D-mannopyranosyl-(1→2)-3-O-benzyl-4,6-
O-benzylidene-β-D-mannopyranosyl-(1→2)-3-O-benzyl-4,6-O-
benzylidene-D-mannopyranosyl]  dibenzylphosphate (16).  Method 1: To 
a solution of 15 (35 mg, 1 equivalent) in 4 ml dry CH2Cl2 under argon was 
added 1H-tetrazole  (6.3 mg, 3.8 equivalents)  after which the solution was 
cooled  down to 0 °C. Dibenzyl(N,N-diisopropyl) phosphoramidite  (22 µl, 
2.5 equivalents)  was added and the reaction mixture was allowed to return 
to  room  temperature  and was stirred  for  2  h. The reaction  mixture  was 
cooled down to –60 °C and m-CPBA (13.5 mg, 3.8 equivalents) was added 
and the mixture was stirred at 0 °C for 1 h and then at room temperature for  
1 h. The reaction mixture was diluted with 50 ml CH2Cl2 and washed with 2 
× 15 ml of a saturated solution of Na2S2O3 in H2O, 2 × 15 ml of a saturated 
solution  of NaHCO3 in H2O and 2 × 10 ml H2O after  which  the organic 
layer  was  dried  over  NasSO4 and  concentrated  to  dryness.  The  crude 
product was purified by column chromatography (hexane : EtOAc 1 : 1, Rf 
= 0.57) Yield of α-product: 25 mg (60 %). [α] D = – 61,2 ° (c = 0,1 CH2Cl2, 
24 °C).
Method 2: To a solution  of  12 (50 mg, 1 equivalent)  in 3 ml dry CH2Cl2 
under  argon  was  added  PO(OBn)2Oh (26.7  mg,  3  equivalents)  and 4  Å 
molecular sieves. The reaction mixture was cooled down to –50 °C and NIS 
(8.6  mg,  1.2  equivalents)  and TMSOTf  (0.7  µl,  0.12  equivalents)  were  
added. The reaction mixture was stirred at –50 °C for 1 h and warmed to –
20 °C  and stirred  for  3.5 h after  which additional  TMSOTf (0.7 µl, 0.12 
equivalents)  was added  and the reaction  mixture  was  stirred  for  another  
17.5 h at –20 °C. The reaction  was quenched  by adding 0.5 ml pyridine 
after which the reaction mixture was diluted with 20 ml CH2Cl2 and washed 
with 2 × 15 ml of a saturated solution of Na2S2O3 in H2O, 2 × 15 ml of a 
saturated solution of NaHCO3 in H2O and 1 × 15 ml H2O. The organic layer 
was dried over Na2SO4 and evaporated  to dryness. The crude product was 
purified  by  column  chromatography  (hexane  :  EtOAc  1:1).  Yield  of  α-
product: 26 mg (47%).  1H NMR (600.13 MHz, CDCl3, 25 °C): δ =7.75 – 
6.75 (m, 55 H, arom. H), 5.59 (dd, 1 H, JH-1, H-2 = 1.7 Hz, JH-1, P = 6.3 Hz, H-
1), 5.56 (s, 1 H, 4,6-OCHʹʹʹPh), 5.43 (s, 1 H, 4,6-OCHPh), 5.41 (s and s, 2 
H, 4,6-OCHʹPh and 4,6-OCHʹʹPh), 5.14 (d, 1 H, J ʹʹ ʹʹH-1 , H-2 ʹʹ = 0.1 Hz, H-1 ), 
5.08 and 5.02 [each dd, each, 1 H, J = –11.9 Hz, JCH2a,P = 9.1 Hz, JCH2b,P = 
8.2 Hz, PO(OCH2Ph)],  5.06 (d, 1 H, J ʹʹʹ ʹʹʹH-1 ,  H-2 ʹʹʹ = 0.1 Hz, H-1 ), 5.01 and 
4.98 [each dd, each, 1 H, J = –11.6 Hz, JCH2a,P = 8.4 Hz, JCH2b,P = 9.9 Hz, 
PO(OCH2Ph)],  4.99  and  4.83  (each  d,  each  1  H, J ʹʹʹ =  –12.5  Hz,  2 -
OCH2Ph), 4.70 and 4.63 (each d, each 1 H, J ʹ = –12.4 Hz, 3 -OCH2Ph), 4.65 
and 4.50 (each d, each 1 H, J ʹʹ = –11.9 Hz, 3 -OCH2Ph), 4.64 and 4.61 (each 
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d, each 1 H, J = –12.4 Hz, 3-OCH2Ph), 4.51 (dd, J ʹʹ ʹʹH-2 , H-3 ʹʹ = 3.1 Hz, H-2 ), 
4.50 (d, 1 H, J ʹ ʹH-1 , H-2 ʹ = H-1 ), 4.50 and 4.38 (each d, each 1 H,  J = –11.8 Hz, 
ʹʹʹ3 -OCH2Ph), 4.42 (dd, 1 H, J ʹ ʹH-2 , H-3 ʹ = 3.3 Hz, H-2 ), 4.39 (dd, 1 H, J ʹʹʹ ʹʹʹH-2 , H-3  
ʹʹ ʹ= 3.1 Hz, H-2 ), 4.36 (dd, 1 H, J ʹʹ ʹʹH-6 a, H-5  = 4.6 Hz, J ʹʹ ʹʹH-6 a, H-6 b = –10.2 Hz, H-
ʹʹ6 a), 4.26 (dd, 1 H, J ʹ ʹH-6 a, H-5  = 4.8 Hz, J ʹ ʹH-6 a, H-6 b ʹ = –10.2 Hz, H-6 a), 4.18 (dd, 
1 H, J ʹʹʹ ʹʹʹH-4 , H-5  = 9.2 Hz, J ʹʹʹ ʹʹʹH-4 , H-3 ʹʹ ʹ = 9.9 Hz, H-4 ), 4.17 (dd, 1 H, J ʹʹʹ ʹʹʹH-6 a, H-5  = 
4.8 Hz, J ʹʹʹ ʹʹ ʹH-6 a, H-6 b ʹʹʹ = –10.4 Hz, H-6 a), 4.10 (dd, 1 H, JH-2, H-3 = 3.7 Hz, H-2), 
4.07 (dd, 1 H, J ʹʹ ʹʹH-4 , H-5  = 9.3 Hz, J ʹʹ ʹʹH-4 , H-3 ʹʹ = 9.8 Hz, H-4 ), 3.98 (dd, 1 H, JH-6a, 
H-5 = 4.9 Hz, JH-6a, H-6b = –10.3 Hz, H-6a), 3.88 (dd, 1 H, J ʹ ʹH-4 , H-5  = 9.4 Hz, JH-
ʹ ʹ4 , H-3 ʹ = 9.9 Hz, H-4 ), 3.85 (dd and dd, 2 H,  J ʹʹʹ ʹʹʹH-6 b, H-5  = 10.1 Hz, JH-4, H-5 = 9.5 
Hz, JH-4, H-3 ʹʹʹ = 10.1 Hz, H-6 b and H-4), 3.82 (ddd, 1 H, JH-5, H-6b = 10.3 Hz, 
H-5), 3.80 (dd, 1 H, H-3), 3.78 (dd, 1 H, J ʹʹ ʹʹH-6 b, H-5 ʹʹ = 10.0 Hz, H-6 b), 3.73 
(dd, 1 H, J ʹ ʹH-6 b, H-5 ʹ ʹ = 10.0 Hz, H-6 b), 3.62 (dd, 1 H, H-3 ), 3.55 (dd, 1 H, H-
ʹʹ ʹʹʹ ʹʹ6b), 3.53 (dd, 1 H, H-3 ), 3.52 (dd, 1 H, H-3 ), 3.40 (ddd, 1 H, H-5 ), 3.31 
ʹʹʹ ʹ(ddd, 1 H, H-5 ), 3.27 (ddd, 1 H, H-5 ) ppm.
13C NMR (150.9 MHz, CDCl3, 25 °C): δ = 139.4 – 126.1 (arom. C), 103.3 
ʹʹʹ ʹʹ(C-1 ),  101.9  (C-1 ,  4,6-OCHPh,  4,6-OCʹHPh),  101.5  (4,6-OCʹʹHPh), 
101.2 (4,6-OCʹ ʹHPh), 100.5 (C-1 ), 95.7 (2JC-1, P ʹʹʹ = 4.9 Hz, C-1), 79.0 (C-3 ), 
ʹʹʹ ʹ ʹʹ ʹʹ ʹʹ78.4 (C-4 ), 78.3 (C-4 ), 71.2 (C-4, C-4 ), 76.8 (C-3 ), 76.2 (C-2 ), 76.1 
ʹ ʹʹʹ(C-3 ), 75.9 (C-2 ), 74.9 (3JC-2,  P ʹʹʹ = 9.3 Hz, C-2), 74.6 (2 -OCH2Ph), 74.2 
ʹ ʹʹʹ(C-2 ), 73.4 (C-3), 72.2 (3 -OCH2Ph), 72.1 (3-OCH2 ʹPh), 71.3 (3 -OCH2Ph), 
ʹʹ70.8  (3 -OCH2Ph),  69.9  [2JC,P =  5.4  Hz,  2JC,P =  5.8  Hz,  PO(OCaH2Ph), 
PO(OCbH2 ʹʹ ʹʹʹ ʹPh)], 68.8 (C-6 ), 68.7 (C-6 ), 68.6 (C-6 ), 68.3 (C-6), 68.0 (C-
ʹʹ ʹ ʹʹʹ5 ), 67.7 (C-5 ), 67.5 (C-5 ), 65.5 (C-5) ppm.
31P NMR (242.9 MHz, CDCl3, 25 °C): δ = –2.92 ppm.
HRMS:  m/z calcd.  for  C101H101O24PNa  [M  +  Na]+:  1751.6318;  Found 
1751.6341.
β-D-Mannopyranosyl-(1→2)-β-D-mannopyranosyl-(1→2)-β-D-
mannopyranosyl-(1→2)-α-D-mannopyranosylphosphate  (18): 
Synthesized  from  16 (25  mg,  0.014  mmol)  according  to  the  general 
procedure for hydrogenolysis of benzyl and benzylidene protecting groups.  
Filtration  through celite  with  a 4:1  mixture  of MeOH  : H2O yielded  the 
product as a colorless oil. Yield: 7 mg (67%). [α]D = – 15 ° (c = 0.01 H2O, 
24 °C). 1H NMR (600.13 MHz, CDCl3, 25 °C): δ = 5.47 (dd, 1 H, JH-1, H-2 = 
1.4 Hz, JH-1,  P ʹʹ ʹʹʹ = 7.8 Hz, H-1), 4.96 (s, 1 H, H-1 ), 4.94 (s, 1 H, H-1 ), 4.93 
ʹ(s, 1 H, H-1 ), 4.43 (d, 1 H, J ʹʹ ʹʹH-2 , H-3 ʹʹ = 3.4 Hz, H-2 ), 4.29 (d, 1 H, J ʹ ʹH-2 , H-3  = 
ʹ3.4 Hz, H-2 ), 4.16 (dd and d, 2 H, JH-2, H-3 = 3.2 Hz, J ʹʹʹ ʹʹʹH-2 , H-3  = 3.4 Hz, H-2 
ʹʹʹand H-2 ), 4.00 (dd, 1 H, JH-3, H-4 = 9.9 Hz, H-3), 3.94 (dd, 1 H, J ʹ ʹH-6 a, H-5  = 
3.1 Hz, J ʹ ʹH-6 a, H-6 b ʹ = –12.3 Hz, H-6 a), 3.93  (dd, 1 H, J ʹʹʹ ʹʹʹH-6 a, H-5  = 2.5 Hz, J ʹʹʹH-6 a, 
ʹʹ ʹH-6 b ʹʹʹ = –12.3 Hz, H-6 a), 3.92 (dd, 1 H, J ʹʹ ʹʹH-6 a, H-5  = 2.1 Hz, J ʹʹ ʹʹH-6 a, H-6 b = –11.9 
ʹʹHz, H-6 a), 3.87 (dd, 1 H,  JH-6a,  H-5 = 2.0 Hz,  JH-6a,  H-6b = –12.3 Hz, H-6a), 
3.84 (ddd, 1 H, JH-5, H-6b = 4.6 Hz, JH-5, H-4 = 10.1 Hz, H-5), 3.77 (dd, 1 H, H-
6b), 3.75 (dd, 1 H, J ʹʹ ʹʹH-6 b, H-5 ʹʹ = 6.3 Hz, H-6 b), 3.73 (dd and dd, J ʹʹʹ ʹʹʹH-6 b, H-5  = 
6.5 Hz, J ʹ ʹH-3 , H-4 ʹʹʹ ʹ = 8.9 Hz, H-6 b and H-3 ), 3.72 (dd, 1 H, J ʹ ʹH-6 b, H-5  = 5.5 Hz, 
ʹH-6 b), 3.66 (dd, 1 H, J ʹʹ ʹʹH-3 , H-4 ʹʹ = 10.0 Hz, H-3 ), 3.62 (dd, 1 H, J ʹʹʹ ʹʹʹH-3 , H-4  = 
ʹʹʹ9.5 Hz, H-3 ), 3.60 (dd 1 H, H-4), 3.58 (dd, 1 H, J ʹʹ ʹʹH-4 , H-5 ʹʹ = 9.2 Hz, H-4 ), 
3.56 (dd, 1 H, J ʹʹʹ ʹʹʹH-4 , H-5 ʹʹʹ = 9.7 Hz, H-4 ), 3.51 (dd, 1 H, J ʹ ʹH-4 , H-5  = 10.2 Hz, H-
ʹ ʹ ʹʹʹ ʹʹ4 ), 3.42 (ddd,  1  H, H-5 ), 3.39  (ddd, 1 H, H-5 ), 3.38 (ddd, 1 H, H-5 ) 
ppm.
13C NMR (150.9 MHz, CDCl3 ʹʹ ʹʹʹ, 25 °C): δ = 101.2 (C-1 ), 101.0 (C-1 ), 99.1  
ʹ(C-1 ), 93.2 (2JC-1, P ʹ = 5.8 Hz, C-1), 79.4 (C-2 ), 78.9  (3JC-2, P = 8.4 Hz, C-2), 
ʹʹ ʹʹ ʹʹʹ ʹ ʹʹʹ78.4 (C-2 ), 76.2, 76.2 (C-5 , C-5 ), 75.9 (C-5 ), 72.9 (C-5, C-3 ), 72.1 (C-
ʹʹ ʹ ʹʹʹ ʹ3 ), 71.8 (C-3 ), 70.4 (C-2 ), 68.9 (C-3), 67.3 (C-4), 67.1 (C-4 ), 66.9, 66.7 
ʹʹ ʹʹ ʹ ʹ ʹʹʹ ʹʹ(C-4 , C-4 ), 61.1 (C-6 ), 60.7 (C-6 ), 60.5 (C-6 ), 60.3 (C-6) ppm.
31P NMR (242.9 MHz, CDCl3, 25 °C): δ = 1.6 ppm.
HRMS: m/z calcd. for C24H42O24P [M - H]-: 745.1804; Found 745.1835.
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